The table below shows the development of the Biotest shares over the past years.
The XETRA prices shown in euros have been adjusted for the capital measures and the share split.
|Xetra price in Euro||2012||2013||2014||2015||2016||2017||2018||2019|
|Ordinary shares||Price at close of year||16.917||26.000||29.767||18.700||15.900||22.605||26.000||19.200|
|Highest rate intraday||18.000||26.133||31.343||35.300||18.710||29.090||32.200||26.400|
|Lowest rate intraday||12.767||17.000||22.833||12.765||11.700||15.950||19.900||19.050|
|Preference Shares||Price at close of year||16.399||25.333||31.333||15.400||13.390||20.200||23.500||20.500|
|Highest rate intraday||16.399||26.217||33.333||38.133||16.590||23.880||27.200||23.850|
|Lowest rate intraday||11.975||16.033||23.003||12.130||10.305||13.280||18.660||19.860|
In 2012 the total number of share outstanding (weighted average) was 11,728,575. On 15 July 2015 Biotest AG reorganises stock exchange listing due to share split with the ration one to three. By implementing the capital increase and the share split the existing shareholder structure does not change.
In 2013 a capital increase took place by issuing new 1,461,909 preference shares. The number of shares outstanding (weighted average) was 12.465.537 in 2013.
The share prices for 2014 in the table relate to a total number of share of 13,190,484 shares (divided into 6,595,242 ordinary shares and 6,595,242 preference shares) before the sharesplit on 15 July 2015 and the implemented capital increase.
The share capital of Biotest AG amounted to 33,767,639.04 before the capital increase and was divided into 6,595,242 ordinary shares and 6,595,242 preference shares without voting rights. Thus, one ordinary or preference share had a proportional amount of the share capital of € 2.56. After the implementation of the capital increase from capital funds by 5,803,812.96 to 39,571,452.00 without issuing new shares and the share split, each former holder of one existing ordinary or preference share now holds three ordinary or preference shares with a proportional amount of the share capital of € 1.00. After capital increase and share split the ordinary shares and prefernece share amount to each 19,785,726 shares.